Evaluationoof0theoRole0ofoGabapentin0and/oroOmega-30in0Uremic Pruritusofor0PatientsoUndergoing0Hemodialysis0 | Zendy

Sinan Forat Hussein | Zendy; Kadhim Ali Kadhim | Zendy; Ali Jassim Al Sultani | Zendy; Saad Abdulrahman Hussain | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluationoof0theoRole0ofoGabapentin0and/oroOmega-30in0Uremic Pruritusofor0PatientsoUndergoing0Hemodialysis0

Author(s) -

Sinan Forat Hussein,

Kadhim Ali Kadhim,

Ali Jassim Al Sultani,

Saad Abdulrahman Hussain

Publication year - 2017

Publication title -

al mustansiriyah journal of pharmaceutical sciences

Language(s) - English

Resource type - Journals

eISSN - 2959-183X

pISSN - 1815-0993

DOI - 10.32947/ajps.v17i2.157

Subject(s) - medicine , gabapentin , stage (stratigraphy) , parathyroid hormone , gastroenterology , drug , pharmacology , biology , pathology , alternative medicine , calcium , paleontology

Uremicopruritus,0isochronic0itchingothat0occursoin0patientsowith0advancedoor0 end-stage renal0disease.oIt0isoone0ofocommon0symptomsoinopatients00with00end-stage renal0 diseaseowith0approximatelyo60–90%0ofopatients0on0hemodialysis(HD) suffering0fromothis0problem. This study wasodesigned0to evaluate theoefficacy0and safety of prescribing Gabapentinoand0Omega-3 in combination or aloneofor0relieving uremicopruritus0in Iraqi patients undergoing0hemodialysis. The resultsoshowed0that all the threeoinvolved0regimens0(gabapentin, omega-3,0and the combinationoof0both drugs) had0significantly reduced the pruritus score. Furthermore,0theocombination0was significantlyosuperior0tooother0regimens in reducingopruritus 0score, owhile0no0significant effect0wasoobserved0by oallothe regimensoon0interleukin-6oor0on parathyroid hormone serum0levels.In Conclusion Gabapentin0100mgoplus01000mg0omega-30based fishooil capsules containing 120mg0DHA and0180mg0EPA isosuperior0to each drug alone0in reducing pruritus scoreoin0a0sample0of Iraqi0patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research